Search Results

Showing results 1001 - 1010 for blood cells from the endothelial cells

Roger Hartl, M.D. | Patient Care

...cells"....

https://weillcornell.org/rhartl

Stadtfeld, Matthias

...generation of allg-iPS cell mice from terminally differentiated B cells. ...

http://vivo.med.cornell.edu/display/cwid-mas4011

Academic Article

...humerus Modular Immune Organoids with Integrin Ligand Specificity Differentially Regulate Ex Vivo B Cell...

http://vivo.med.cornell.edu/individuallist?page=2051&vclassId=http%3A%2F%2Fpurl.org%2Fontology%2Fbibo%2FAcademicArticle

Academic Article

...Control of cell-growth and differentiation by the cyclin/cdk/rb pathway Control of chaos in excitable...

http://vivo.med.cornell.edu/individuallist?page=797&vclassId=http%3A%2F%2Fpurl.org%2Fontology%2Fbibo%2FAcademicArticle

News | Newsroom | Weill Cornell Medicine

...Blood Vessel Repair Cells July 3, 2024 Endothelial cells with a distinct gene-expression signature...

https://news.weill.cornell.edu/news?page=13

Article

...cells Academic Article Suburban versus urban: does it matter where the residency interview begins?...

http://vivo.med.cornell.edu/individuallist?page=3983&vclassId=http%3A%2F%2Fpurl.org%2Fontology%2Fbibo%2FArticle

wnim_2022-03.pdf

...Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF- mediated...

https://medicine.weill.cornell.edu/sites/default/files/wnim_2022-03.pdf

Weill Department of Medicine 2021 Annual Report

...Jones and collaborators published breakthrough findings in Blood regarding T-cells from recovered COVID...

https://medicine.weill.cornell.edu/sites/default/files/2021arfull.pdf

Keeping Cancer from Fertile Ground: Weill Cornell Team Identifies Key Players in 'Pre-Metastasis' | Newsroom | Weill Cornell Medicine

...Like most adult stem cells, these "vascular endothelial growth factor receptor 1+" (VEGFR1+) cells are...

https://news.weill.cornell.edu/news/2005/12/keeping-cancer-from-fertile-ground-weill-cornell-team-identifies-key-players-in-pre-metastasis

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib. | Pathology & Laboratory Medicine

...Line, Cell Proliferation, Cell Survival, Drug Screening Assays, Antitumor, Endothelial Cells, Enzyme...

https://pathology.weill.cornell.edu/research/publications/cep-18770-novel-orally-active-proteasome-inhibitor-tumor-selective

Showing results 1001 - 1010 for blood cells from the endothelial cells